Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis - Wikidata - awgldk - TriplyDB

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

http://www.wikidata.org/entity/Q57422892

about

On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection Infectious mononucleosis.Emerging infectious diseases: vulnerabilities, contributing factors and approaches The evolution of sex-specific virulence in infectious diseases Epstein-Barr virus particles induce centrosome amplification and chromosomal instability.Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor.Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma Dendritic cells during Epstein Barr virus infection.Maternal and perinatal factors associated with hospitalised infectious mononucleosis in children, adolescents and young adults: record linkage study.Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.Exhausted cytotoxic control of Epstein-Barr virus in human lupus.The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders Hodgkin lymphoma among US solid organ transplant recipients Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)Role for early-differentiated natural killer cells in infectious mononucleosis Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma EBV in Hodgkin Lymphoma.Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.Epstein-Barr virus-associated lymphomas.Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation Epstein-barr virus vaccines.Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.Infectious etiologies of childhood leukemia: plausibility and challenges to proof.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders Long-term cancer risk among people diagnosed with AIDS during childhood Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells Epstein-barr virus: environmental trigger of multiple sclerosis?Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.

P2860

Q24645207-407A35EF-D4C3-4C23-A34C-951F4B268125 Q26776151-4D1AB52C-FF3B-46C6-A82E-591ED788DB2C Q28069456-CC054C83-055B-460A-81A4-7946455D6609 Q28084340-F843AC0E-6017-4506-B355-EF04B10234BC Q28287659-95F33AEE-A90F-4002-AC8F-6A63F6037E97 Q28733461-595AA735-18B6-4DDE-81F1-F957AE227D96 Q30838642-5C4DBA65-0BFB-498C-BB28-32E502BE9E23 Q30978395-219EF9A0-9D5F-4FE6-A7D1-1FBC31BF0890 Q33283515-189AC192-CDF9-4A2B-8B23-A229DF067392 Q33372701-A67AE194-809E-499F-A168-B2E090C8C73C Q33570474-858BEC44-9E46-4424-A936-B29C969089A5 Q33582609-D2A0CF97-34AE-4D2D-8F99-2649A86B7D4E Q33729564-822FA0F9-2529-4DE9-A146-C530C323C231 Q33778708-9FF95C87-B079-43FF-AB05-E38692B43020 Q33782152-7C0B38EF-B202-45E1-8C86-CC5DDD31DC0E Q33831002-BBCABCDF-28FB-4CCD-8B88-A7A714A5D037 Q34009363-556D4EAE-7F19-4CCB-827C-A5B34756BD1A Q34058156-387D918A-9EDF-4DEB-8489-A5B0DA566BA7 Q34166602-01003392-8870-4352-BC7A-3A91AFBD5B55 Q34258853-998985C6-AB7C-4FA7-AAC9-F4F9BE4F6FFC Q34352415-D6B1CC43-BC17-44C3-9553-B6C072EF49A9 Q34353708-263F906C-03D5-4A9F-8691-C2CE3C3D7635 Q34408939-216798DB-AC59-464B-B634-31C60923C214 Q34549468-B23D2D30-7DA5-4B3D-B18D-9D402EFD4B85 Q34576340-7B335D52-F8F0-4928-9665-BB78CF906BA4 Q34651670-B5ECBD84-0F2C-4B2A-AD4B-5B2050D04D56 Q35001573-996BF4CE-B9E2-4E7F-8B05-4D912D80490C Q35036813-CAD533CD-2ADA-415A-8479-1800B96255F6 Q35053650-7CD5A591-65FC-4AD0-B0E9-24ECADD0571E Q35223805-27744BC4-9621-4EB2-9434-253A674D224B Q35539719-FCADEE30-4689-41EB-B60C-83170AB65541 Q35554572-0BD63D86-7101-4172-9042-218279BC7F85 Q35637884-C8D3407B-C15B-43F7-BC3F-72BC213629FA Q35669222-4810A8D7-9194-463C-936B-497C6D1B8193 Q35672129-05F279CA-CAF1-441B-8EE2-2712E25FF3C0 Q35738744-44AB1D8D-68F8-4F37-B759-5E55A6AC4079 Q35851884-ED7A1D71-82D2-459E-A370-53169B2E6254 Q35857336-D7E949FD-7DE6-42D9-9654-20638E5EA6DA Q35914342-DFB35414-7E75-4B87-837F-EBAFF9CBD7A0 Q36003614-EF910DCB-FD20-4DDB-B46C-1D00452BEB90

P2860

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

http://www.wikidata.org/entity/Q57422892

description

im Oktober 2003 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2003

@uk

name

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@en

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@nl

type

label

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@en

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@nl

prefLabel

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@en

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@nl

P1433

Q57422892-C21A6BC6-ACC7-4583-A04B-769FD6B587D4

P1476

Q57422892-4869EA02-343D-44BF-B6E9-4D6FF63E5251

P2093

Q57422892-03C3BD99-3FE8-418F-8CDA-F7EA99E53F19

Q57422892-5447EDC7-F2AD-4FE4-AC00-B31B5997599D

Q57422892-8C0154A1-211F-4CF6-A849-EC938724522A

Q57422892-9B26F2BF-B2C9-4341-8184-750A05DA8DE2

Q57422892-D1C7FF01-CB76-453D-900B-7CAA152D26B0

Q57422892-FD0ED7E8-5A77-44EA-A88B-55387B7BAA52

P304

Q57422892-33FF84C8-9FB5-4CAF-B83A-99E1674D31E5

P31

Q57422892-E0E7D036-1EB8-47B8-8E3F-445BB035FA3C

P356

Q57422892-DEBEDE8F-D528-4041-B3C4-9613C7E07AF2

P407

Q57422892-5F6E4B1B-9D3B-4DA4-87BA-4AE99BBEC358

P433

Q57422892-2BCCF78F-BDA5-4BF8-9892-E9CCA362B9C8

P478

Q57422892-3E08D569-1B8E-4F19-9421-5A94E8D78672

P50

Q57422892-832D549B-6CFA-4F99-846C-025477869DD7

Q57422892-BDCFFC21-B42C-459D-818C-9EE27E8BBA35

Q57422892-E4EBFA68-4011-44F7-8D82-9EB0D7245012

Q57422892-E8DB0F69-3239-489B-BDC9-400A2F5E713A

Q57422892-FEACFC30-7AA1-450D-B230-18A430581871

P577

Q57422892-48749320-B5E8-4183-9263-6C83FFFB5965

P698

Q57422892-5FC680F7-50EC-4862-B579-DF4334A19152

P356

P1433

The New England Journal of Medicine

P1476

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

@en

P2093

Hans H. Storm

http://www.w3.org/2001/XMLSchema#string

Helle Bossen Konradsen

http://www.w3.org/2001/XMLSchema#string

Jin-Song Zhang

http://www.w3.org/2001/XMLSchema#string

Johan Askling

http://www.w3.org/2001/XMLSchema#string

Mette Madsen

http://www.w3.org/2001/XMLSchema#string

Nils Rosdahl

http://www.w3.org/2001/XMLSchema#string

P304

1324-1332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA023141

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

Klaus Rostgaard

Stephen Hamilton-Dutoit

Henrik Hjalgrim

P577

2003-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14523140

http://www.w3.org/2001/XMLSchema#string